{"name":"Spectrum Pharmaceuticals, Inc","slug":"spectrum-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"SPI-2012","genericName":"SPI-2012","slug":"spi-2012","indication":"Advanced or metastatic solid tumors","status":"phase_3"},{"name":"VLI","genericName":"VLI","slug":"vli","indication":"Hodgkin lymphoma","status":"marketed"},{"name":"Zevalin","genericName":"Zevalin","slug":"zevalin","indication":"Follicular non-Hodgkin's lymphoma","status":"discontinued"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Belinostat, Warfarin","genericName":"Belinostat, Warfarin","slug":"belinostat-warfarin","indication":"Other","status":"phase_1"},{"name":"Qapzola","genericName":"Qapzola","slug":"qapzola","indication":"Other","status":"discontinued"}]}],"pipeline":[{"name":"Belinostat, Warfarin","genericName":"Belinostat, Warfarin","slug":"belinostat-warfarin","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Qapzola","genericName":"Qapzola","slug":"qapzola","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SPI-2012","genericName":"SPI-2012","slug":"spi-2012","phase":"phase_3","mechanism":"SPI-2012 is a selective inhibitor of polo-like kinase 1 (PLK1) that disrupts cell cycle progression and induces apoptosis in cancer cells.","indications":["Advanced or metastatic solid tumors","Non-Hodgkin's lymphoma"],"catalyst":""},{"name":"VLI","genericName":"VLI","slug":"vli","phase":"marketed","mechanism":"VLI is a vinca alkaloid that inhibits microtubule assembly by binding to tubulin, disrupting cell division and causing cell death in rapidly dividing cancer cells.","indications":["Hodgkin lymphoma","Non-Hodgkin lymphoma","Acute lymphoblastic leukemia","Breast cancer","Lung cancer"],"catalyst":""},{"name":"Zevalin","genericName":"Zevalin","slug":"zevalin","phase":"discontinued","mechanism":"B-lymphocyte antigen CD20","indications":["Follicular non-Hodgkin's lymphoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOSUtjX24wVHdvVjlYV3dYNWFtdTlRYXI2bnVuY1pGVUxsNDBqZlJrWHAwbmM5ME9MRG1NT3pNYTNlbTkwdEVNRjl5WDFFUzliU3pqWHhFT3lfZWJUTkxHMjFxWmlrdjlsa3VnM1ZkQzJTUHA3TmE0T2dqd3Q5ZksxWng1S2RJNnVNcFh4Nlhn?oc=5","date":"2025-07-07","type":"pipeline","source":"Claim Depot","summary":"Claim your share of the $15.95M Spectrum Pharmaceuticals stockholder settlement - Claim Depot","headline":"Claim your share of the $15.95M Spectrum Pharmaceuticals stockholder settlement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxOcXZrUGZmQUJ1bHJCMjZDS3RuWGVtNU5oQm00TWVRcTlrZ1RqOE43amlYSHo0TVUzZ3RHVkNGNExfLWJOeG5DSTl4RHVvTm5wRmZPNjJiMWhZMWlKRGtncHA1OTNSU3RZbElmb0txQ05ET1NocWwzdXBBYjZjSURvVG41VEkwYkJBZmNScVpKcUlXU083eUN4eXJ2a2JLLXpSYWtaaU04UWhINzRTdUdLVFI4aDBIcE5qOTNuZm5Cc2h4OUFLdWFOTEZLTGxBZm1mOHd3?oc=5","date":"2023-07-31","type":"pipeline","source":"GlobeNewswire","summary":"Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals Transaction - GlobeNewswire","headline":"Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals Transaction","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNOHpIV1JkWW50dHZxTEpCLTU5SXp1MEYyTUEyYkdaaWhtYW41eXdUeFpic2pKRmFGREZDSlVwQmllckhXT2hYckpGWTlNanpDT1JETGpSUEZNVGIwS01FZW9BVmxhM2xXT2xlcHZsaFFCVDYtVjM3LXh4Qm95SURPaEVzWUVkQm1vV2h4OEY2UlI2emloWGR4aTgtZFV5LXhad1prY1VLb09vUzZhRW4w?oc=5","date":"2023-04-26","type":"pipeline","source":"lw.com","summary":"Latham & Watkins Advises Assertio Holdings in Acquisition of Spectrum Pharmaceuticals - lw.com","headline":"Latham & Watkins Advises Assertio Holdings in Acquisition of Spectrum Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQeHdKVDU2Q0Z6cEdlUGRaTXhYVjcwalFNOVRIQWk0blFIcVNRYUNHSnZYUjF2X3FNQTFJYXcyeFVsRFp2NDRMcUZlUDBKZHpZaG0xSHlYZnBrc1VZc3pwMVI2dGpNN3FoaENPdlgzV28tbC10OTAtSm91NHRYc2dMdUNVT0k1WWhmR2JnT1FrZkI3cktDSUcw?oc=5","date":"2023-04-25","type":"regulatory","source":"Fierce Pharma","summary":"Assertio picks up Spectrum and its approved drug Rolvedon in $248M-plus deal - Fierce Pharma","headline":"Assertio picks up Spectrum and its approved drug Rolvedon in $248M-plus deal","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPcDNDaHdxd2JDNllMTW9lMEpiSkU1c1ZVLUg5aWs4UFRjVUxyakIxdU9CY1EyOGluTjZsc3NLcVdtX3VncHhxTUM4UjRJMjhLeklwaVdKYjFKNjdjZ3FHQmozcDNzMVJKMnpqLW9pU1BtTFYyajBIenF2MFIwOFdaVm82NC1rN2otbFE?oc=5","date":"2023-04-25","type":"deal","source":"Yahoo Finance","summary":"Assertio Scoops Up Spectrum Pharma In $248M Stock Deal - Yahoo Finance","headline":"Assertio Scoops Up Spectrum Pharma In $248M Stock Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxQZ3JsVGk2YzdtU25rV3JHdVNIX0FrTGZVd2MyTVFMalBoR3MwVEdRUXNMdzFicGJKSnEtSFVRMzJrXzBkd1ZpVFRTMjdveWw5T21MWXpMc0xJUnF3X3JUSDFCUzlIbnFkaXVlWkF4Tl9INDVIeUVMT0I1WXAwbGJKTEJFbG1xZWx0NHRUVnFXVVdQR2Y4cFlPQ2k4Z2lTR2VXUzhYdjl5RFpITDdnQVdpUVhPczh5dHY5aHZieXJ4QkNuUFA2bWd2TG9rclQzWU02b3ljZUNzemh5eWQ5bnVkSHZCNDZOdVdyb1c3MDZQNEFnZWNkaHpnOWpR?oc=5","date":"2023-04-25","type":"deal","source":"GlobeNewswire","summary":"Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR Transaction - GlobeNewswire","headline":"Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR Transaction","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPcTlEcVY2RDF6OG9SV2pqenlQYmNhM0cxWVRzSzRRVUQxM24zemdqZkxJTzR5eVZLbFVBd2pFLTljRm5PUHlINlZXSkZGVHQzV2s0eEhERW05ejFaX3ptZVBnUktEMTNxa09iT1ZPSDJVTE80dHlNU1hmQzM3VkFCOE9ucw?oc=5","date":"2023-03-29","type":"pipeline","source":"Pharmacy Times","summary":"Rolvedon From Spectrum Pharmaceuticals, Inc - Pharmacy Times","headline":"Rolvedon From Spectrum Pharmaceuticals, Inc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE15dTNtZWpGOHp0R2pHR2x5UXJiMEFEeW1VZkEwSk5IeU5hWEZZRVRvd0tzNkthZmU4My1xQmw1N3RyZnRkQXBYS2FLRzBncjR3THI4cWFBbFlSbmE1Q3dXTUswVWwzd0NxSVpHVll3?oc=5","date":"2022-09-13","type":"regulatory","source":"KED Global","summary":"Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum - KED Global","headline":"Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQT2hUSHN5V2g3YmQzcjE5ZmxiYWVCdmpKQmlpaHRsLW9kdGRWM2hhcWlaU0hUNm9nalRJOG9PbUYwTU93TktXWFBGRkNHNldwRDZsZjZfTHMwMm9ibktfazI3WlhtQmM4dUpTR3Y5TGRlZGZFOVRGU0hEQXJGd1doU0ZBMGhHNUc1NVoxQzE4WGx6ZXdwNjNKSEV5VQ?oc=5","date":"2022-01-06","type":"pipeline","source":"The Pharma Letter","summary":"Spectrum Pharma restructuring will see 30% job cuts - The Pharma Letter","headline":"Spectrum Pharma restructuring will see 30% job cuts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTFBob1lsaVk4VDh3c2xpOERrMzlzYnJ1d3RyRHM5dEItZ1Q3QldlS2tDMERoenFWSlBGa3ZWTW1SWVd1OFUxQVlrNWVDejRHNmdycTd6aFJxOFl4ZG90MGpBcnpEdS1XY1ZZMEdFV2htT0ZMNkVrY2c?oc=5","date":"2022-01-05","type":"pipeline","source":"Pharma Voice","summary":"Flying Sky High -- Rajesh C. Shrotriya - Pharma Voice","headline":"Flying Sky High -- Rajesh C. Shrotriya","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1JSzZoVThib3lPdXRmOGpXM3FKY0dtSG9LQzQzYzBVX2pKT3hkQl9ENE1Mc2VCZmZhbGF6YWtZYlBGZnZnaElITGI3ZlZ6RE5US0pJU2x2cFlVSVRrVmpKYjFmNVA1ODRzQ245UE5XMnJjWEMwMVZF?oc=5","date":"2019-01-17","type":"pipeline","source":"Orange County Business Journal","summary":"Spectrum Pharma to Sell Drug Portfolio - Orange County Business Journal","headline":"Spectrum Pharma to Sell Drug Portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNYnVqcXdKZlUwdW5SbXlrOHU5ZzNSSkxocW50dGFuc2FRUzh0MVBqYnhVTFROeXUtVU1hUVY2ZGJyNkNvQ21OM3dSeE52VHM3c2E0bGNjaHBCazE2RlludFZNd2tLWkRmLUJLczlOSWtkNU93Y2F1ZV9lUDFsZU9xbkw2WkJGYlBvcE9VbWZ3TXFIQWFsTmhn?oc=5","date":"2015-04-03","type":"pipeline","source":"Barron's","summary":"Spectrum Pharma May Be a Two-Blockbuster Stock - Barron's","headline":"Spectrum Pharma May Be a Two-Blockbuster Stock - Barron's","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_1":1,"discontinued":2,"phase_3":1,"marketed":1},"enrichmentLevel":0,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}